How EMA’s PRIME Scheme Accelerates Rare Disease Therapies
How EMA’s PRIME Scheme Accelerates Rare Disease Therapies Accelerating Rare Disease Treatments Through the EMA PRIME Scheme Introduction to the PRIME Scheme The Priority Medicines (PRIME) scheme was launched by the European Medicines Agency (EMA) in 2016 to enhance support for the development of medicines targeting unmet medical needs. PRIME provides early and proactive regulatory…
Read More “How EMA’s PRIME Scheme Accelerates Rare Disease Therapies” »